190 related articles for article (PubMed ID: 37316798)
1. Piperacillin-tazobactam induced immune hemolytic anemia led to increased renal impairment and eventual death from multiple organ failure in a patient with hypertensive nephropathy: case report and literature review.
Wu Y; Wu Y; Guo G; Zeng J; Liu Y; Wu Y
BMC Nephrol; 2023 Jun; 24(1):173. PubMed ID: 37316798
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic anemia as a result of piperacillin/tazobactam administration: a case report and discussion of pathophysiology.
Zanetti RC; Biswas AK
Mil Med; 2013 Sep; 178(9):e1045-7. PubMed ID: 24005557
[TBL] [Abstract][Full Text] [Related]
3. Case report: Decreased hemoglobin and multiple organ failure caused by ceftizoxime-induced immune hemolytic anemia in a Chinese patient with malignant rectal cancer.
Lou C; Liu M; Ma T; Yang L; Long D; Li J; Lei H; Xiang D; Wang X; Li L; Cai X
Front Immunol; 2024; 15():1390082. PubMed ID: 38756782
[TBL] [Abstract][Full Text] [Related]
4. Piperacillin-tazobactam-induced haemolytic anaemia after multiple courses of therapy.
Gerhardy B; Bowler S
Intern Med J; 2021 Mar; 51(3):458. PubMed ID: 33738942
[No Abstract] [Full Text] [Related]
5. Two cases of immune haemolytic anaemia, associated with anti-piperacillin, detected by the 'immune complex' method.
Arndt PA; Garratty G; Hill J; Kasper M; Chandrasekaran V
Vox Sang; 2002 Oct; 83(3):273-8. PubMed ID: 12366773
[TBL] [Abstract][Full Text] [Related]
6. The First-Reported Case of Drug-Induced Hemolytic Anemia by Piperacillin-Tazobactam in a Premature Neonate: A Case Report and Literature Review.
Salim H; Musmar B; A Sarhan FM; Giacaman N; Abu Omar S
Cureus; 2023 Mar; 15(3):e35915. PubMed ID: 37038577
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies.
Wu Y; Wu Y; Ji Y; Liu Y; Wu D; Liang J; Guo G; Chen B
Front Med (Lausanne); 2021; 8():723167. PubMed ID: 34646843
[TBL] [Abstract][Full Text] [Related]
8. Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy.
Wu Y; Wu Y; Ji Y; Liang J; He Z; Liu Y; Tang L; Guo G
Front Med (Lausanne); 2021; 8():697192. PubMed ID: 34485334
[TBL] [Abstract][Full Text] [Related]
9. Serological studies of piperacillin antibodies.
Leger RM; Arndt PA; Garratty G
Transfusion; 2008 Nov; 48(11):2429-34. PubMed ID: 18657075
[TBL] [Abstract][Full Text] [Related]
10. Risk of piperacillin-induced hemolytic anemia in patients with cystic fibrosis and antipseudomonal treatment: a prospective observational study.
Roehmel J; Specht P; Staab D; Schwarz C; Salama A; Mayer B
Transfusion; 2019 Dec; 59(12):3746-3754. PubMed ID: 31724753
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis.
Bandara M; Seder DB; Garratty G; Leger RM; Zuckerman JB
Case Rep Med; 2010; 2010():161454. PubMed ID: 20589083
[TBL] [Abstract][Full Text] [Related]
12. Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.
Kunzmann S; Thomas W; Mayer B; Kuhn S; Hebestreit H
Infection; 2010 Apr; 38(2):131-4. PubMed ID: 20213286
[TBL] [Abstract][Full Text] [Related]
13. Haemolytic anaemia caused by piperacillin-tazobactam.
Dapper I; Nauwynck M; Selleslag D; Hidajat M; Bourgeois M; Martens P; Wilmer A
Acta Clin Belg; 2009; 64(6):517-9. PubMed ID: 20101875
[TBL] [Abstract][Full Text] [Related]
14. Immune hemolytic anemia caused by drugs.
Garratty G
Expert Opin Drug Saf; 2012 Jul; 11(4):635-42. PubMed ID: 22502777
[TBL] [Abstract][Full Text] [Related]
15. Hematologic adverse effects induced by piperacillin-tazobactam: a systematic review of case reports.
Wang Q; He Z; Wu X; Wei Y; Huang J
Int J Clin Pharm; 2020 Aug; 42(4):1026-1035. PubMed ID: 32500262
[TBL] [Abstract][Full Text] [Related]
16. [Drug-induced immune hemolytic anemia: a retrospective study of 10 cases].
Bollotte A; Vial T; Bricca P; Bernard C; Broussolle C; Sève P
Rev Med Interne; 2014 Dec; 35(12):779-89. PubMed ID: 24908632
[TBL] [Abstract][Full Text] [Related]
17. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
Front Immunol; 2021; 12():698541. PubMed ID: 35003054
[TBL] [Abstract][Full Text] [Related]
18. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.
Leicht HB; Weinig E; Mayer B; Viebahn J; Geier A; Rau M
BMC Pharmacol Toxicol; 2018 Oct; 19(1):67. PubMed ID: 30359322
[TBL] [Abstract][Full Text] [Related]
19. Piperacillin-induced immune hemolysis presenting with tachycardia and cardiac arrest.
Lohiya GS; Tan-Figueroa L; Krishna V
Case Rep Med; 2011; 2011():816497. PubMed ID: 22235207
[TBL] [Abstract][Full Text] [Related]
20. Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease.
Bell MJ; Stockwell DC; Luban NL; Shirey RS; Shaak L; Ness PM; Wong EC
Pediatr Crit Care Med; 2005 May; 6(3):363-6. PubMed ID: 15857541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
